Results vary based on dosage, starting weight, nutrition habits, and activity level
Can GLP-1s Treat Emotional Eating and Binge Eating in People With Obesity
By integrating advanced medical technologies and a holistic approach, we strive to enhance your patient experience and support your long-term well-being
FDA sent a letter on October 17, 2024, in response to a question regarding the agencys intended approach to the compounding of tirzepatide drug products during the reevaluation period
Changes in your body weight can be influenced by many factors, including diet, exercise, and other medications
PubMed American Diabetes Association Professional Practice Committee